Tesamorelin Injectable Peptide 5mg

Tesamorelin – Research Peptide for Growth Hormone Modulation and Lipodystrophy Studies

---

Product Usage: All products made available on this website are intended exclusively for research and development purposes and are strictly not for human consumption or therapeutic use. These products are not approved by the U.S. Food and Drug Administration (FDA), and no statements on this website have been evaluated by the FDA. The products and any information provided are not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Our research-grade Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH 1–44), developed for advanced studies into endogenous HGH stimulation, visceral fat reduction, and metabolic regulation. Tesamorelin is best known for its targeted effects on reducing abdominal fat in HIV-associated lipodystrophy, but its broader applications in metabolic and aging research continue to gain interest.

Potential Research Benefits:

• Endogenous HGH Stimulation: Tesamorelin promotes the body’s natural secretion of growth hormone via direct action on the pituitary gland.
• Reduction in Visceral Adipose Tissue (VAT): Clinical studies have shown significant decreases in abdominal fat, especially in lipodystrophy models.
• Metabolic Improvements: Research suggests Tesamorelin may improve lipid profiles, insulin sensitivity, and IGF-1 levels without excessive GH-related side effects.
• Cognitive and Neural Benefits: Some studies indicate potential neuroprotective effects and improvements in cognitive performance in aging models.
• Support for Anti-Aging and Performance Studies: Investigated for its ability to improve body composition, recovery, and overall anabolic signaling in age-related GH decline models.

Clinical Research References:

• Tesamorelin is FDA-approved for HIV-associated lipodystrophy and continues to be studied for broader applications in fat metabolism, aging, and growth hormone regulation.

Storage and Handling:

• Store at 2–8°C (35–46°F) in a refrigerated environment.
• Protect from direct sunlight and high humidity.
• Reconstitute with bacteriostatic water in a sterile research setting and use within 4–6 weeks.

Disclaimer:

This product is intended strictly for research purposes only. Not for human consumption or therapeutic use. Researchers are responsible for ensuring compliance with applicable laws and regulations.